250 related articles for article (PubMed ID: 25407098)
1. Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations.
Grinyó JM; Petruzzelli S
Expert Rev Clin Immunol; 2014 Dec; 10(12):1567-79. PubMed ID: 25407098
[TBL] [Abstract][Full Text] [Related]
2. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.
Alloway RR; Eckhoff DE; Washburn WK; Teperman LW
Liver Transpl; 2014 May; 20(5):564-75. PubMed ID: 24493215
[TBL] [Abstract][Full Text] [Related]
3. Meltdose Tacrolimus Pharmacokinetics.
Baraldo M
Transplant Proc; 2016 Mar; 48(2):420-3. PubMed ID: 27109969
[TBL] [Abstract][Full Text] [Related]
4. Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients.
Gaber AO; Alloway RR; Bodziak K; Kaplan B; Bunnapradist S
Transplantation; 2013 Jul; 96(2):191-7. PubMed ID: 23715050
[TBL] [Abstract][Full Text] [Related]
5. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
[TBL] [Abstract][Full Text] [Related]
6. MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients.
Baccarani U; Velkoski J; Pravisani R; Adani GL; Lorenzin D; Cherchi V; Falzone B; Baraldo M; Risaliti A
Transplant Proc; 2019 Nov; 51(9):2971-2973. PubMed ID: 31607620
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus prolonged release (Envarsus®): a review of its use in kidney and liver transplant recipients.
Garnock-Jones KP
Drugs; 2015 Feb; 75(3):309-20. PubMed ID: 25613762
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus.
Tsuchiya T; Ishida H; Tanabe T; Shimizu T; Honda K; Omoto K; Tanabe K
Transplantation; 2013 Jul; 96(2):198-204. PubMed ID: 23792649
[TBL] [Abstract][Full Text] [Related]
10. Advagraf(®) , a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts.
Caillard S; Moulin B; Buron F; Mariat C; Audard V; Grimbert P; Marquet P
Transpl Int; 2016 Aug; 29(8):860-9. PubMed ID: 26373896
[TBL] [Abstract][Full Text] [Related]
11. Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation.
Oellerich M; Schütz E; Kanzow P; Schmitz J; Beck J; Kollmar O; Streit F; Walson PD
Ther Drug Monit; 2014 Apr; 36(2):136-40. PubMed ID: 24452066
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients.
Tanzi MG; Undre N; Keirns J; Fitzsimmons WE; Brown M; First MR
Clin Transplant; 2016 Aug; 30(8):901-11. PubMed ID: 27220013
[TBL] [Abstract][Full Text] [Related]
13. Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations.
Coilly A; Calmus Y; Chermak F; Dumortier J; Duvoux C; Guillaud O; Houssel-Debry P; Neau-Cransac M; Stocco J
Liver Transpl; 2015 Oct; 21(10):1312-21. PubMed ID: 26264233
[TBL] [Abstract][Full Text] [Related]
14. Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study.
Langone A; Steinberg SM; Gedaly R; Chan LK; Shah T; Sethi KD; Nigro V; Morgan JC;
Clin Transplant; 2015 Sep; 29(9):796-805. PubMed ID: 26113208
[TBL] [Abstract][Full Text] [Related]
15. First clinical experience with the new once-daily formulation of tacrolimus.
First MR
Ther Drug Monit; 2008 Apr; 30(2):159-66. PubMed ID: 18367975
[TBL] [Abstract][Full Text] [Related]
16. Correction to: Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations.
Grinyó JM; Petruzzelli S
Expert Rev Clin Immunol; 2015 Apr; 11(4):547. PubMed ID: 25779682
[No Abstract] [Full Text] [Related]
17. Tacrolimus once-daily formulation in the prophylaxis of transplant rejection in renal or liver allograft recipients: a viewpoint by Sander Florman.
Florman S
Drugs; 2007; 67(13):1944. PubMed ID: 17722964
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics of Once-Daily Extended-Release Tacrolimus Tablets Versus Twice-Daily Capsules in De Novo Liver Transplant.
DuBay DA; Teperman L; Ueda K; Silverman A; Chapman W; Alsina AE; Tyler C; Stevens DR
Clin Pharmacol Drug Dev; 2019 Nov; 8(8):995-1008. PubMed ID: 30667591
[TBL] [Abstract][Full Text] [Related]
19. A UK analysis of the cost of switching renal transplant patients from an immediate-release to a prolonged-release formulation of tacrolimus based on differences in trough concentration variability.
Muduma G; Odeyemi I; Pollock RF
J Med Econ; 2014 Jul; 17(7):520-6. PubMed ID: 24754700
[TBL] [Abstract][Full Text] [Related]
20. Modified release tacrolimus.
First MR; Fitzsimmons WE
Yonsei Med J; 2004 Dec; 45(6):1127-31. PubMed ID: 15627307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
